Companies/Pharmiva AB
Follow

Pharmiva AB

Nasdaq First North GM Stockholm (Sweden)

Pharmiva is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 7
View all
www.pharmiva.com
Current instruments
Type
Ticker
ISIN
SHARE
PHARM
SE0015530670
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
PHARM
SE0015530670
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Pharmiva AB with ticker PHARM
Status
Active
Currency
SEK
First trading date
31 Mar 2021
Exercise
Sign in to buy
Remuneration issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
PHARM
SE0015530670
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Pharmiva AB with ticker PHARM
Status
Active
Currency
SEK
First trading date
31 Mar 2021
Remuneration issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHARM TO3
SE0015658885
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmiva AB with ticker PHARM TO3
Status
Archived
Currency
SEK
Trading period
31 Mar 2021 - 06 Apr 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to seventy (70) percent of the volume weighted average trading price at Nasdaq First North Growth Market Sweden during the twenty (20) trading days prior the exercise period begins, but not less than share quota value (SEK 0.12) and not more than SEK 20 per share. The subscription period with the support of warrants will take place from March 28, 2022 - April 8, 2022.
Update (28.03.2022): Subscription price for warrants TO3 has been set - SEK 5.72 per share.
Exercise
Sign in to buy
People
Anna Linton
CEO
Malte Zaunders
Chairman of the board
Ingrid Atteryd Heiman
Board member
Ulf Blom
Board member
Kristina Ingvar
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Sankt Lars Väg 45B
Zip code
222 70
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559007-0958
LEI code
5493002PYGTLIBQYY395
First trade date
31 Mar 2021
Registration date
12 Mar 2015
Short name
PHARM

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More